The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 44,009 | 2,005,862 | SH | DFND | 1 | 0 | 2,005,862 | 0 | |
5 01 ACQUISITION CORP | COM CL A | 33836P105 | 4,925 | 500,000 | SH | DFND | 1 | 0 | 500,000 | 0 | |
AADI BIOSCIENCES INC | COM | 00032Q104 | 21,720 | 899,392 | SH | DFND | 1 | 0 | 899,392 | 0 | |
AC IMMUNE SA | SHS | H00263105 | 34,959 | 7,062,379 | SH | DFND | 1 | 0 | 7,062,379 | 0 | |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 24,658 | 1,695,904 | SH | DFND | 1 | 0 | 1,695,904 | 0 | |
ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 1,958 | 289,663 | SH | DFND | 1 | 0 | 289,663 | 0 | |
AILERON THERAPEUTICS INC | COM | 00887A105 | 2,964 | 5,265,555 | SH | DFND | 1 | 0 | 5,265,555 | 0 | |
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 22,015 | 1,589,495 | SH | DFND | 1 | 0 | 1,589,495 | 0 | |
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 55,470 | 16,459,965 | SH | DFND | 1 | 0 | 16,459,965 | 0 | |
ANGION BIOMEDICA CORP | COM | 03476J107 | 3,107 | 1,071,297 | SH | DFND | 1 | 0 | 1,071,297 | 0 | |
ARCUS BIOSCIENCES INC | COM | 03969F109 | 137,520 | 3,398,067 | SH | DFND | 1 | 0 | 3,398,067 | 0 | |
ARGENX SE | SPONSORED ADR | 04016X101 | 75,712 | 216,204 | SH | DFND | 1 | 0 | 216,204 | 0 | |
BIONOMICS LIMITED | ADS | 09063M205 | 1,016 | 80,971 | SH | DFND | 1 | 0 | 80,971 | 0 | |
CALITHERA BIOSCIENCES INC | COM | 13089P101 | 4,957 | 7,452,331 | SH | DFND | 1 | 0 | 7,452,331 | 0 | |
CALLIDITAS THERAPEUTICS AB | SPONSERED ADS | 13124Q106 | 18,570 | 750,000 | SH | DFND | 1 | 0 | 750,000 | 0 | |
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 5,118 | 454,545 | SH | DFND | 1 | 0 | 454,545 | 0 | |
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 29,358 | 1,800,000 | SH | DFND | 1 | 0 | 1,800,000 | 0 | |
CIDARA THERAPEUTICS INC | COM | 171757107 | 8,714 | 6,861,127 | SH | DFND | 1 | 0 | 6,861,127 | 0 | |
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 7,097 | 2,253,000 | SH | DFND | 1 | 0 | 2,253,000 | 0 | |
COGENT BIOSCIENCES INC | COM | 19240Q201 | 13,147 | 1,532,282 | SH | DFND | 1 | 0 | 1,532,282 | 0 | |
CONTRAFECT CORP | COM NEW | 212326300 | 10,447 | 3,972,300 | SH | DFND | 1 | 0 | 3,972,300 | 0 | |
CORVUS PHARMACEUTICALS INC | COM | 221015100 | 3,304 | 1,370,947 | SH | DFND | 1 | 0 | 1,370,947 | 0 | |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 85,340 | 3,003,879 | SH | DFND | 1 | 0 | 3,003,879 | 0 | |
CTI BIOPHARMA CORP | COM | 12648L601 | 22,146 | 8,929,690 | SH | DFND | 1 | 0 | 8,929,690 | 0 | |
CULLINAN ONCOLOGY INC | COM | 230031106 | 82,851 | 5,369,459 | SH | DFND | 1 | 0 | 5,369,459 | 0 | |
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 25,130 | 5,803,700 | SH | DFND | 1 | 0 | 5,803,700 | 0 | |
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 13,636 | 809,282 | SH | DFND | 1 | 0 | 809,282 | 0 | |
ELEDON PHARMACEUTICALS INC | COM | 28617K101 | 6,077 | 1,378,020 | SH | DFND | 1 | 0 | 1,378,020 | 0 | |
ELEVATION ONCOLOGY INC | COM | 28623U101 | 9,702 | 1,611,698 | SH | DFND | 1 | 0 | 1,611,698 | 0 | |
EQRX INC | COM | 26886C107 | 53,603 | 7,859,670 | SH | DFND | 1 | 0 | 7,859,670 | 0 | |
ERYTECH PHARMA | SPONSORED ADR | 29604W108 | 3,103 | 1,314,656 | SH | DFND | 1 | 0 | 1,314,656 | 0 | |
ESSA PHARMA INC | COM NEW | 29668H708 | 40,491 | 2,851,461 | SH | DFND | 1 | 0 | 2,851,461 | 0 | |
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 4,990 | 500,000 | SH | DFND | 1 | 0 | 500,000 | 0 | |
FORWARD PHARMA A/S | SPONSORD ADS NEW | 34986J204 | 2,584 | 432,892 | SH | DFND | 1 | 0 | 432,892 | 0 | |
FRAZIER LIFESCIENCES ACQU CO | UNIT 12/09/2025 | G3710A121 | 4,950 | 500,000 | SH | DFND | 1 | 0 | 500,000 | 0 | |
GALAPAGOS NV | SPON ADR | 36315X101 | 63,752 | 1,156,393 | SH | DFND | 1 | 0 | 1,156,393 | 0 | |
GALMED PHARMACEUTICALS LTD | SHS | M47238106 | 3,275 | 1,799,694 | SH | DFND | 1 | 0 | 1,799,694 | 0 | |
GENERATION BIO CO | COM | 37148K100 | 1,338 | 189,050 | SH | DFND | 1 | 0 | 189,050 | 0 | |
GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 4,654 | 4,012,404 | SH | DFND | 1 | 0 | 4,012,404 | 0 | |
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 216,389 | 9,275,158 | SH | DFND | 1 | 0 | 9,275,158 | 0 | |
GLYCOMIMETICS INC | COM | 38000Q102 | 13,744 | 9,544,262 | SH | DFND | 1 | 0 | 9,544,262 | 0 | |
IKENA ONCOLOGY INC | COM | 45175G108 | 22,552 | 1,798,371 | SH | DFND | 1 | 0 | 1,798,371 | 0 | |
INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 14,296 | 6,353,645 | SH | DFND | 1 | 0 | 6,353,645 | 0 | |
INVENTIVA SA | ADS | 46124U107 | 7,438 | 544,500 | SH | DFND | 1 | 0 | 544,500 | 0 | |
JANUX THERAPEUTICS INC | COM | 47103J105 | 20,072 | 1,017,314 | SH | DFND | 1 | 0 | 1,017,314 | 0 | |
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,931 | 300,000 | SH | DFND | 1 | 0 | 300,000 | 0 | |
KURA ONCOLOGY INC | COM | 50127T109 | 28,899 | 2,064,212 | SH | DFND | 1 | 0 | 2,064,212 | 0 | |
KYMERA THERAPEUTICS INC | COM | 501575104 | 201,940 | 3,180,658 | SH | DFND | 1 | 0 | 3,180,658 | 0 | |
LEXICON PHARMACEUTICALS INC | COM NEW | 528872302 | 56,578 | 14,360,000 | SH | DFND | 1 | 0 | 14,360,000 | 0 | |
MEI PHARMA INC | COM NEW | 55279B202 | 9,431 | 3,532,057 | SH | DFND | 1 | 0 | 3,532,057 | 0 | |
MERUS N V | COM | N5749R100 | 131,495 | 4,135,071 | SH | DFND | 1 | 0 | 4,135,071 | 0 | |
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 6,953 | 435,936 | SH | DFND | 1 | 0 | 435,936 | 0 | |
MOLECULAR PARTNERS AG | ADS | 60853G106 | 8,550 | 443,221 | SH | DFND | 1 | 0 | 443,221 | 0 | |
MOLECULAR TEMPLATES INC | COM | 608550109 | 12,268 | 3,129,599 | SH | DFND | 1 | 0 | 3,129,599 | 0 | |
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 16,913 | 955,000 | SH | DFND | 1 | 0 | 955,000 | 0 | |
NUVALENT INC | COM | 670703107 | 8,540 | 448,512 | SH | DFND | 1 | 0 | 448,512 | 0 | |
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 69,372 | 7,411,503 | SH | DFND | 1 | 0 | 7,411,503 | 0 | |
OVID THERAPEUTICS INC | COM | 690469101 | 21,286 | 6,631,051 | SH | DFND | 1 | 0 | 6,631,051 | 0 | |
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 20,141 | 5,328,239 | SH | DFND | 1 | 0 | 5,328,239 | 0 | |
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 16,355 | 2,920,526 | SH | DFND | 1 | 0 | 2,920,526 | 0 | |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 124,890 | 3,651,759 | SH | DFND | 1 | 0 | 3,651,759 | 0 | |
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 19,651 | 1,791,351 | SH | DFND | 1 | 0 | 1,791,351 | 0 | |
RAIN THERAPEUTICS INC | COM | 75082Q105 | 38,097 | 2,957,807 | SH | DFND | 1 | 0 | 2,957,807 | 0 | |
RELAY THERAPEUTICS INC | COM | 75943R102 | 96,141 | 3,130,605 | SH | DFND | 1 | 0 | 3,130,605 | 0 | |
RELMADA THERAPEUTICS INC | COM | 75955J402 | 37,116 | 1,647,400 | SH | DFND | 1 | 0 | 1,647,400 | 0 | |
REPARE THERAPEUTICS INC | COM | 760273102 | 102,471 | 4,858,761 | SH | DFND | 1 | 0 | 4,858,761 | 0 | |
REPLIMUNE GROUP INC | COM | 76029N106 | 25,109 | 926,529 | SH | DFND | 1 | 0 | 926,529 | 0 | |
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 4,860 | 500,000 | SH | DFND | 1 | 0 | 500,000 | 0 | |
REVOLUTION MEDICINES INC | COM | 76155X100 | 45,572 | 1,810,549 | SH | DFND | 1 | 0 | 1,810,549 | 0 | |
REZOLUTE INC | COM NEW | 76200L309 | 912 | 190,815 | SH | DFND | 1 | 0 | 190,815 | 0 | |
SELECTA BIOSCIENCES INC | COM | 816212104 | 5,617 | 1,723,133 | SH | DFND | 1 | 0 | 1,723,133 | 0 | |
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 15,600 | 666,666 | SH | DFND | 1 | 0 | 666,666 | 0 | |
SPERO THERAPEUTICS INC | COM | 84833T103 | 25,386 | 1,585,615 | SH | DFND | 1 | 0 | 1,585,615 | 0 | |
SUTRO BIOPHARMA INC | COM | 869367102 | 13,766 | 925,148 | SH | DFND | 1 | 0 | 925,148 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 45,963 | 2,099,714 | SH | DFND | 1 | 0 | 2,099,714 | 0 | |
TYRA BIOSCIENCES INC | COM | 90240B106 | 26,358 | 1,873,332 | SH | DFND | 1 | 0 | 1,873,332 | 0 | |
VERASTEM INC | COM | 92337C104 | 34,977 | 17,062,158 | SH | DFND | 1 | 0 | 17,062,158 | 0 | |
VIRACTA THERAPEUTICS INC | COM | 92765F108 | 12,552 | 3,438,944 | SH | DFND | 1 | 0 | 3,438,944 | 0 | |
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 37,156 | 1,879,412 | SH | DFND | 1 | 0 | 1,879,412 | 0 | |
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 60 | 22,200 | SH | DFND | 1 | 0 | 22,200 | 0 | |
X4 PHARMACEUTICALS INC | COM | 98420X103 | 1,942 | 847,879 | SH | DFND | 1 | 0 | 847,879 | 0 | |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 102,765 | 3,289,540 | SH | DFND | 1 | 0 | 3,289,540 | 0 | |
XOMA CORP DEL | COM NEW | 98419J206 | 73,612 | 3,530,543 | SH | DFND | 1 | 0 | 3,530,543 | 0 |